Journal of Neurochemistry

Cover image for Vol. 143 Issue 5

Edited By: Jörg Schulz

Impact Factor: 4.083

ISI Journal Citation Reports © Ranking: 2016: 66/259 (Neurosciences); 78/290 (Biochemistry & Molecular Biology)

Online ISSN: 1471-4159

Recently Published Issues

See all

Submit an Article

Read online

Why publish with Journal of Neurochemistry?

Quality peer review by top researchers

Simplified and easy submission process

Fast decision times - 27 days to first decision

Rapid online publication, within 2 days of acceptance

Expanded access for your article - all review articles are free from online publication and Non Open Access content is free 12 months after publication

Submit an Article
Become an ISN member

OA Option

Find ISN on Facebook

ISN Facebook page

Recently Published Articles

  1. Fibroblast Growth Factor 2 Regulates Activity and Gene Expression of Human Postmitotic Excitatory Neurons

    Shweta Gupta, Tanya M-Redmond, Fan Meng, Andrew Tidball, Huda Akil, Stanley Watson, Jack M. Parent and Michael Uhler

    Accepted manuscript online: 23 NOV 2017 11:23AM EST | DOI: 10.1111/jnc.14255

  2. Functional properties of dopamine transporter oligomers after copper linking

    Juan Zhen and Maarten E. A. Reith

    Accepted manuscript online: 23 NOV 2017 11:21AM EST | DOI: 10.1111/jnc.14259

  3. You have free access to this content
    New tool to tackle Alzheimer's disease: amyloid-β protofibril-selective antibody AbSL : An Editorial Highlight for ‘The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region’ on doi:10.1111/jnc.14211

    Elek Molnár

    Version of Record online: 23 NOV 2017 | DOI: 10.1111/jnc.14240

    Thumbnail image of graphical abstract

    This Editorial highlights a study by Colvin et al. (2017) in the current issue of Journal of Neurochemistry, in which the authors describe the development and characterisation of a new rabbit antibody (termed antibody St. Louis; AbSL) that preferentially recognises amyloid-β (Aβ) protein 42 (Aβ42) protofibrils over other Aβ species.

  4. The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region

    Benjamin A. Colvin, Victoria A. Rogers, Joshua A. Kulas, Elizabeth A. Ridgway, Fatima S. Amtashar, Colin K. Combs and Michael R. Nichols

    Version of Record online: 22 NOV 2017 | DOI: 10.1111/jnc.14211

    Thumbnail image of graphical abstract

    Aggregation and accumulation of amyloid-β peptide (Aβ) is a key component of Alzheimer's disease (AD). The aggregation process yields a variety of soluble (protofibrils) and insoluble (fibrils) species. Because of the importance of protofibrils, an antiserum, termed AbSL, was developed and found to be selective for Aβ protofibrils over monomers and fibrils. The newly developed antibody may have potential diagnostic and therapeutic uses.

    Read the Editorial Highlight for this article on doi: 10.1111/jnc.14240.

  5. Repair gene MGMT is controlled by SP1 and upregulated by glucocorticoids, but not by temozolomide and radiation

    Dorthe Aasland, Thomas R. Reich, Maja T. Tomicic, Olivier J. Switzeny, Bernd Kaina and Markus Christmann

    Accepted manuscript online: 22 NOV 2017 01:30AM EST | DOI: 10.1111/jnc.14262